Suzhou‑Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere
CompanyDeals

Suzhou‑Based InnoBM Partners with Qilu Pharmaceutical on BM601 Metallic Embolic Microsphere

Shanghai Henlius Biotech Negotiates Potential Sale of HLX43 ADC to Johnson & Johnson and Roche
CompanyDeals

Shanghai Henlius Biotech Negotiates Potential Sale of HLX43 ADC to Johnson & Johnson and Roche

Shenzhen Mindray Eyes $1 B+ Hong Kong IPO With Huatai, JPMorgan On Board
CompanyDeals

Shenzhen Mindray Eyes $1 B+ Hong Kong IPO With Huatai, JPMorgan On Board

Duoning Bio Secures Global License for Upstream Bio’s Biochemical Analyzer Portfolio
CompanyDeals

Duoning Bio Secures Global License for Upstream Bio’s Biochemical Analyzer Portfolio

CSPC's ALMB-0166 Approved for Phase II Trials in Parkinson's Disease
Drug

CSPC’s ALMB-0166 Approved for Phase II Trials in Parkinson’s Disease

Nanjing Leads Biolabs Doses First Patient in Opamtistomig Melanoma Trial
CompanyDrug

Nanjing Leads Biolabs Doses First Patient in Opamtistomig Melanoma Trial

AstraZeneca Launches Ultomiris in China for gMG and NMOSD Treatments
CompanyDrug

AstraZeneca Launches Ultomiris in China for gMG and NMOSD Treatments

AstraZeneca Pauses GBP 200m Cambridge R&D Investment Amid UK Funding Cuts
Company

AstraZeneca Pauses GBP 200m Cambridge R&D Investment Amid UK Funding Cuts

Novo Nordisk Rybelsus Gains Cardio Benefit from SOUL Trial
CompanyDrug

Novo Nordisk Rybelsus Gains Cardio Benefit from SOUL Trial

Guangzhou Baiyunshan Pharmaceutical Launches Phase I/II Trial for RET‑Targeted BYS10
Drug

Guangzhou Baiyunshan Pharmaceutical Launches Phase I/II Trial for RET‑Targeted BYS10

Sino Biopharmaceutical Secures NMPA Approval for Degarelix Generic in China
CompanyDrug

Sino Biopharmaceutical Secures NMPA Approval for Degarelix Generic in China

Haisco Pharma Secures NMPA Approval for Anrikefon in Hemodialysis‑Related Pruritus
CompanyDrug

Haisco Pharma Secures NMPA Approval for Anrikefon in Hemodialysis‑Related Pruritus